XML 99 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value
8. Fair Value
Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below.
 
June 30, 2014
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
102,024

 
$
7,369

 
$
109,393

Foreign corporate

 
55,876

 
6,612

 
62,488

Foreign government

 
54,955

 
1,672

 
56,627

U.S. Treasury and agency
32,103

 
21,924

 
320

 
54,347

RMBS
1,330

 
33,789

 
3,945

 
39,064

CMBS

 
15,056

 
595

 
15,651

ABS

 
11,002

 
3,786

 
14,788

State and political subdivision

 
14,663

 
35

 
14,698

Total fixed maturity securities
33,433

 
309,289

 
24,334

 
367,056

Equity securities:
 
 
 
 
 
 
 
Common stock
1,615

 
906

 
186

 
2,707

Non-redeemable preferred stock

 
893

 
263

 
1,156

Total equity securities
1,615

 
1,799

 
449

 
3,863

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities

 
670

 
20

 
690

FVO general account securities
503

 
70

 
109

 
682

FVO contractholder-directed unit-linked investments
11,533

 
4,337

 
571

 
16,441

FVO securities held by CSEs

 
7

 
11

 
18

Total FVO and trading securities
12,036

 
5,084

 
711

 
17,831

Short-term investments (1)
4,309

 
5,723

 
246

 
10,278

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 
367

 
367

Commercial mortgage loans held by CSEs — FVO

 
638

 

 
638

Total mortgage loans

 
638

 
367

 
1,005

Other invested assets:
 
 
 
 
 
 

Other investments
259

 
67

 

 
326

Derivative assets: (2)
 
 
 
 
 
 


Interest rate
3

 
6,417

 
44

 
6,464

Foreign currency exchange rate
1

 
1,081

 
35

 
1,117

Credit

 
163

 
18

 
181

Equity market
1

 
1,167

 
322

 
1,490

Total derivative assets
5

 
8,828

 
419

 
9,252

Total other invested assets
264

 
8,895

 
419

 
9,578

Net embedded derivatives within asset host contracts (3)

 

 
328

 
328

Separate account assets (4)
87,503

 
235,783

 
1,691

 
324,977

Total assets
$
139,160

 
$
567,211

 
$
28,545

 
$
734,916

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (2)
 
 
 
 
 
 
 
Interest rate
$
6

 
$
1,899

 
$
8

 
$
1,913

Foreign currency exchange rate

 
1,512

 
38

 
1,550

Credit

 
50

 
1

 
51

Equity market
11

 
1,340

 
717

 
2,068

Total derivative liabilities
17

 
4,801

 
764

 
5,582

Net embedded derivatives within liability host contracts (3)

 
8

 
(692
)
 
(684
)
Long-term debt of CSEs — FVO

 
490

 
15

 
505

Trading liabilities (5)
218

 

 

 
218

Total liabilities
$
235

 
$
5,299

 
$
87

 
$
5,621

 
December 31, 2013
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
99,321

 
$
7,148

 
$
106,469

Foreign corporate

 
56,448

 
6,704

 
63,152

Foreign government

 
52,202

 
2,235

 
54,437

U.S. Treasury and agency
25,061

 
20,000

 
62

 
45,123

RMBS

 
32,098

 
2,957

 
35,055

CMBS

 
15,578

 
972

 
16,550

ABS

 
11,361

 
4,210

 
15,571

State and political subdivision

 
13,820

 
10

 
13,830

Total fixed maturity securities
25,061

 
300,828

 
24,298

 
350,187

Equity securities:
 
 
 
 
 
 
 
Common stock
1,186

 
990

 
177

 
2,353

Non-redeemable preferred stock

 
654

 
395

 
1,049

Total equity securities
1,186

 
1,644

 
572

 
3,402

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities
2

 
648

 
12

 
662

FVO general account securities
518

 
80

 
29

 
627

FVO contractholder-directed unit-linked investments
10,702

 
4,806

 
603

 
16,111

FVO securities held by CSEs

 
23

 

 
23

Total FVO and trading securities
11,222

 
5,557

 
644

 
17,423

Short-term investments (1)
5,915

 
6,943

 
254

 
13,112

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 
338

 
338

Commercial mortgage loans held by CSEs — FVO

 
1,598

 

 
1,598

Total mortgage loans

 
1,598

 
338

 
1,936

Other invested assets:
 
 
 
 
 
 
 
Other investments
188

 
71

 

 
259

Derivative assets: (2)
 
 
 
 
 
 
 
Interest rate
10

 
5,557

 
27

 
5,594

Foreign currency exchange rate
1

 
1,280

 
28

 
1,309

Credit

 
144

 
29

 
173

Equity market
1

 
1,233

 
285

 
1,519

Total derivative assets
12

 
8,214

 
369

 
8,595

Total other invested assets
200

 
8,285

 
369

 
8,854

Net embedded derivatives within asset host contracts (3)

 

 
285

 
285

Separate account assets (4)
89,960

 
225,776

 
1,465

 
317,201

Total assets
$
133,544

 
$
550,631

 
$
28,225

 
$
712,400

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (2)
 
 
 
 
 
 
 
Interest rate
$
9

 
$
2,568

 
$
14

 
$
2,591

Foreign currency exchange rate
1

 
1,971

 
39

 
2,011

Credit

 
52

 

 
52

Equity market
43

 
1,222

 
602

 
1,867

Total derivative liabilities
53

 
5,813

 
655

 
6,521

Net embedded derivatives within liability host contracts (3)

 
4

 
(973
)
 
(969
)
Long-term debt of CSEs — FVO

 
1,427

 
28

 
1,455

Trading liabilities (5)
260

 
2

 

 
262

Total liabilities
$
313

 
$
7,246

 
$
(290
)
 
$
7,269

__________________
(1)
Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
(2)
Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
(3)
Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented within PABs and other liabilities on the consolidated balance sheets. At June 30, 2014 and December 31, 2013, equity securities also included embedded derivatives of ($170) million and ($145) million, respectively.
(4)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.
(5)
Trading liabilities are presented within other liabilities on the consolidated balance sheets.
The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.
Investments
Valuation Controls and Procedures
On behalf of the Company’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of MetLife, Inc.’s Board of Directors regarding compliance with fair value accounting standards.
The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent 1% of the total estimated fair value of fixed maturity securities and 15% of the total estimated fair value of Level 3 fixed maturity securities.
The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.
Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities
When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.
When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.
The estimated fair value of investments in certain separate accounts included in FVO general account securities, FVO securities held by CSEs, other investments, long-term debt of CSEs — FVO and trading liabilities is determined on a basis consistent with the methodologies described herein for securities.
Level 2 Valuation Techniques and Key Inputs:
This level includes securities priced principally by independent pricing services using observable inputs. FVO and trading securities, short-term investments and other investments within this level are of a similar nature and class to the Level 2 fixed maturity securities and equity securities. Contractholder-directed unit-linked investments reported within FVO and trading securities include mutual fund interests without readily determinable fair values given prices are not published publicly. Valuation of these mutual funds is based upon quoted prices or reported net asset value (“NAV”) provided by the fund managers, which were based on observable inputs.
U.S. corporate and foreign corporate securities
These securities are principally valued using the market and income approaches. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques that use standard market observable inputs such as benchmark yields, spreads off benchmark yields, new issuances, issuer rating, duration, and trades of identical or comparable securities. Privately-placed securities are valued using matrix pricing methodologies using standard market observable inputs, and inputs derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer, and in certain cases, delta spread adjustments to reflect specific credit-related issues.
Foreign government and state and political subdivision securities
These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques using standard market observable inputs, including a benchmark U.S. Treasury yield or other yields, issuer ratings, broker-dealer quotes, issuer spreads and reported trades of similar securities, including those within the same sub-sector or with a similar maturity or credit rating.
U.S. Treasury and agency securities
These securities are principally valued using the market approach. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques using standard market observable inputs such as a benchmark U.S. Treasury yield curve, the spread off the U.S. Treasury yield curve for the identical security and comparable securities that are actively traded.
Structured securities comprised of RMBS, CMBS and ABS
These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using standard market inputs, including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information, including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans.
Common and non-redeemable preferred stock
These securities are principally valued using the market approach. Valuations are based principally on observable inputs, including quoted prices in markets that are not considered active.
Level 3 Valuation Techniques and Key Inputs:
In general, securities classified within Level 3 use many of the same valuation techniques and inputs as described previously for Level 2. However, if key inputs are unobservable, or if the investments are less liquid and there is very limited trading activity, the investments are generally classified as Level 3. The use of independent non-binding broker quotations to value investments generally indicates there is a lack of liquidity or a lack of transparency in the process to develop the valuation estimates, generally causing these investments to be classified in Level 3.
FVO and trading securities and short-term investments within this level are of a similar nature and class to the Level 3 securities described below; accordingly, the valuation techniques and significant market standard observable inputs used in their valuation are also similar to those described below.
U.S. corporate and foreign corporate securities
These securities, including financial services industry hybrid securities classified within fixed maturity securities, are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques that utilize unobservable inputs or inputs that cannot be derived principally from, or corroborated by, observable market data, including illiquidity premium, delta spread adjustments to reflect specific credit-related issues, credit spreads; and inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on independent non-binding broker quotations.
Foreign government, U.S. Treasury and agency and state and political subdivision securities
These securities are principally valued using the market approach. Valuations are based primarily on independent non-binding broker quotations and inputs, including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on matrix pricing that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads.
Structured securities comprised of RMBS, CMBS and ABS
These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads. Below investment grade securities and sub-prime RMBS included in this level are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain of these valuations are based on independent non-binding broker quotations.
Common and non-redeemable preferred stock
These securities, including privately-held securities and financial services industry hybrid securities classified within equity securities, are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using inputs such as comparable credit rating and issuance structure. Certain of these securities are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2 and independent non-binding broker quotations.
Mortgage Loans
The Company has elected the FVO for commercial mortgage loans held by CSEs and certain residential mortgage loans held-for-investment.
Level 2 Valuation Techniques and Key Inputs:
Commercial mortgage loans held by CSEs  FVO
These investments are principally valued using the market approach. The principal market for these investments is the securitization market. The Company uses the quoted securitization market price of the obligations of the CSEs to determine the estimated fair value of these commercial loan portfolios. These market prices are determined principally by independent pricing services using observable inputs.
Level 3 Valuation Techniques and Key Inputs:
Residential mortgage loans — FVO
For these investments, the estimated fair values are based primarily on matrix pricing or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data.
Separate Account Assets
Separate account assets are carried at estimated fair value and reported as a summarized total on the consolidated balance sheets. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets. Separate account assets include: mutual funds, fixed maturity securities, equity securities, derivatives, hedge funds, other limited partnership interests, short-term investments and cash and cash equivalents.
Level 2 Valuation Techniques and Key Inputs:
These assets are comprised of investments that are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.” Also included are certain mutual funds and hedge funds without readily determinable fair values as prices are not published publicly. Valuation of the mutual funds and hedge funds is based upon quoted prices or reported NAV provided by the fund managers.
Level 3 Valuation Techniques and Key Inputs:
These assets are comprised of investments that are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.” Also included are other limited partnership interests, which are valued giving consideration to the value of the underlying holdings of the partnerships and by applying a premium or discount, if appropriate, for factors such as liquidity, bid/ask spreads, the performance record of the fund manager or other relevant variables that may impact the exit value of the particular partnership interest.
Derivatives
The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments.”
The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Significant inputs that are observable generally include: interest rates, foreign currency exchange rates, interest rate curves, credit curves and volatility. However, certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant inputs that are unobservable generally include references to emerging market currencies and inputs that are outside the observable portion of the interest rate curve, credit curve, volatility or other relevant market measure. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.
Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.
The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.
Freestanding Derivatives
Level 2 Valuation Techniques and Key Inputs:
This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. These derivatives are principally valued using the income approach.
Interest rate
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and basis curves.
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves and interest rate volatility.
Foreign currency exchange rate
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates and cross currency basis curves.
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates, cross currency basis curves and currency volatility.
Credit
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, credit curves and recovery rates.
Equity market
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, spot equity index levels and dividend yield curves. 
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, spot equity index levels, dividend yield curves and equity volatility.
Level 3 Valuation Techniques and Key Inputs:
These derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. These valuation methodologies generally use the same inputs as described in the corresponding sections above for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.
Interest rate
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve and basis curves.
Option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve, basis curves and interest rate volatility.
Foreign currency exchange rate
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve, basis curves, cross currency basis curves and currency correlation.
Option-based. Significant unobservable inputs may include currency correlation and the extrapolation beyond observable limits of the swap yield curve, basis curves, cross currency basis curves and currency volatility.
Credit
Non-option-based. Significant unobservable inputs may include credit spreads, repurchase rates and the extrapolation beyond observable limits of the swap yield curve and credit curves. Certain of these derivatives are valued based on independent non-binding broker quotations.
Equity market
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves and equity volatility.
Option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves, equity volatility and unobservable correlation between model inputs.
Embedded Derivatives
Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees and equity or bond indexed crediting rates within certain funding agreements and within certain annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.
The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs on the consolidated balance sheets.
The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates.
Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.
The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc.
Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.
The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.
The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.
The estimated fair value of the embedded equity and bond indexed derivatives contained in certain funding agreements is determined using market standard swap valuation models and observable market inputs, including a nonperformance risk adjustment. The estimated fair value of these embedded derivatives are included, along with their funding agreements host, within PABs with changes in estimated fair value recorded in net derivative gains (losses). Changes in equity and bond indices, interest rates and the Company’s credit standing may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.
The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs on the consolidated balance sheets.
The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.
Embedded Derivatives Within Asset and Liability Host Contracts
Level 3 Valuation Techniques and Key Inputs:
Direct and assumed guaranteed minimum benefits
These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.
Reinsurance ceded on certain guaranteed minimum benefits
These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and Assumed Guaranteed Minimum Benefits” and also include counterparty credit spreads.
Transfers between Levels
Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.
Transfers between Levels 1 and 2:
For assets and liabilities measured at estimated fair value and still held at June 30, 2014, transfers between Levels 1 and 2 were not significant. For assets and liabilities measured at estimated fair value and still held at December 31, 2013, transfers between Levels 1 and 2 were $101 million.
Transfers into or out of Level 3:
Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.
Transfers into Level 3 for fixed maturity securities and FVO and trading securities were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments, or credit spreads.
Transfers out of Level 3 for fixed maturity securities, equity securities, FVO and trading securities, short-term investments and separate account assets resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings.
Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
June 30, 2014
 
December 31, 2013
 
Impact of
Increase in Input
on Estimated
Fair Value (2)
 
Valuation
Techniques
 
Significant
Unobservable Inputs
 
Range
 
Weighted
Average (1)
 
Range
 
Weighted
Average (1)
 
Fixed maturity securities (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate and foreign corporate
Matrix pricing
 
Delta spread adjustments (4)
 
(5)
-
190
 
34
 
(10)
-
240
 
46
 
Decrease
 
 
 
 
Illiquidity premium (4)
 
30
-
30
 
30
 
30
-
30
 
30
 
Decrease
 
 
 
 
Credit spreads (4)
 
(1,473)
-
706
 
129
 
(1,489)
-
876
 
174
 
Decrease
 
 
 
 
Offered quotes (5)
 
-
120
 
98
 
4
-
145
 
100
 
Increase
 
Market pricing
 
Quoted prices (5)
 
-
369
 
120
 

 

 

 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
31
-
700
 
234
 
33
-
145
 
95
 
Increase
Foreign government
Matrix pricing
 
Credit spreads (4)
 
53
-
56
 
54
 
4
-
72
 
32
 
Decrease
 
Market pricing
 
Quoted prices (5)
 
1
-
153
 
102
 
64
-
156
 
100
 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
66
-
140
 
113
 
84
-
156
 
107
 
Increase
RMBS
Matrix pricing and
discounted cash flow
 
Credit spreads (4)
 
220
-
582
 
375
 
(136)
-
3,609
 
288
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
-
120
 
100
 
10
-
109
 
98
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
1
-
111
 
92
 
69
-
101
 
93
 
Increase (6)
CMBS
Matrix pricing and
discounted cash flow
 
Credit spreads (4)
 
(89)
-
833
 
137
 
215
-
2,025
 
409
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
1
-
105
 
96
 
70
-
104
 
97
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
15
-
104
 
101
 
90
-
101
 
95
 
Increase (6)
ABS
Matrix pricing and
discounted cash flow
 
Credit spreads (4)
 
111
-
1,879
 
327
 
30
-
1,878
 
145
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
-
106
 
101
 
-
110
 
101
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
-
106
 
99
 
56
-
106
 
98
 
Increase (6)
Derivatives
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Interest rate
Present value techniques
 
Swap yield (7)
 
267
-
353
 
 
 
248
-
450
 
 
 
Increase (12)
Foreign currency exchange rate
Present value techniques
 
Swap yield (7)
 
(19)
-
972
 
 
 
97
-
767
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
39%
-
47%
 
 
 
38%
-
47%
 
 
 
 
Credit
Present value techniques
 
Credit spreads (9)
 
99
-
101
 
 
 
98
-
101
 
 
 
Decrease (9)
 
Consensus pricing
 
Offered quotes (10)
 
 

 
 
 
 
 
 
 
 
 
 
 
Equity market
Present value techniques
or option pricing models
 
Volatility (11)
 
11%
-
25%
 
 
 
13%
-
28%
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
60%
-
60%
 
 
 
60%
-
60%
 
 
 
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and assumed guaranteed minimum benefits
Option pricing
techniques
 
Mortality rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ages 0 - 40
 
0%
-
0.28%
 
 
 
0%
-
0.14%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 41 - 60
 
0.04%
-
0.88%
 
 
 
0.04%
-
0.88%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 61 - 115
 
0.26%
-
100%
 
 
 
0.26%
-
100%
 
 
 
Decrease (13)
 
 
 
 
Lapse rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Durations 1 - 10
 
0.50%
-
100%
 
 
 
0.50%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 11 - 20
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 21 - 116
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
Utilization rates
 
20%
-
50%
 
 
 
20%
-
50%
 
 
 
Increase (15)
 
 
 
 
Withdrawal rates
 
0%
-
20%
 
 
 
0%
-
40%
 
 
 
(16)
 
 
 
 
Long-term equity volatilities
 
7.56%
-
40%
 
 
 
9.14%
-
40%
 
 
 
Increase (17)
 
 
 
 
Nonperformance risk spread
 
(0.26)%
-
0.73%
 
 
 
(1.08)%
-
0.83%
 
 
 
Decrease (18)
______________

(1)
The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
(2)
The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
(3)
Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
(4)
Range and weighted average are presented in basis points.
(5)
Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
(6)
Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
(7)
Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(8)
Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
(9)
Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
(10)
At both June 30, 2014 and December 31, 2013, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
(11)
Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(12)
Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
(13)
Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(14)
Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(15)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(16)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(17)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(18)
Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The residential mortgage loans — FVO and long-term debt of CSEs — FVO are valued using independent non-binding broker quotations and internal models including matrix pricing and discounted cash flow methodologies using current interest rates. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”
The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Three Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,378

 
$
6,501

 
$
1,545

 
$
45

 
$
3,439

 
$
682

 
$
2,800

 
$
21

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
4

 
(1
)
 
96

 

 
25

 

 
1

 

Net investment gains (losses)
 
7

 
(3
)
 

 

 

 

 
2

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
108

 
339

 
(91
)
 

 
81

 
(8
)
 
(3
)
 

Purchases (3)
 
487

 
394

 
118

 
301

 
802

 
15

 
1,616

 
2

Sales (3)
 
(455
)
 
(323
)
 
(96
)
 
(26
)
 
(209
)
 
(34
)
 
(259
)
 

Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
253

 
223

 
284

 

 

 

 
121

 
12

Transfers out of Level 3 (4)
 
(413
)
 
(518
)
 
(184
)
 

 
(193
)
 
(60
)
 
(492
)
 

Balance, end of period
 
$
7,369

 
$
6,612

 
$
1,672

 
$
320

 
$
3,945

 
$
595

 
$
3,786

 
$
35

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
2

 
$
(2
)
 
$
1

 
$

 
$
13

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$
(2
)
 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Three Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
203

 
$
441

 
$
11

 
$
29

 
$
624

 
$
11

 
$
1,032

 
$
352

 
$

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
11

 
6

 

 
1

 
8

 

Net investment gains (losses)
 
(2
)
 
(3
)
 

 

 

 

 

 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
40

 
15

 

 

 

 

 

 

 

Purchases (3)
 
24

 

 
19

 

 
281

 

 
212

 
24

 

Sales (3)
 
(2
)
 

 
(2
)
 

 
(270
)
 

 
(461
)
 
(3
)
 

Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 
(14
)
 

Transfers into Level 3 (4)
 
2

 

 

 
69

 
37

 

 

 

 

Transfers out of Level 3 (4)
 
(79
)
 
(190
)
 
(8
)
 

 
(107
)
 

 
(538
)
 

 

Balance, end of period
 
$
186

 
$
263

 
$
20

 
$
109

 
$
571

 
$
11

 
$
246

 
$
367

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
11

 
$
15

 
$

 
$
1

 
$
8

 
$

Net investment gains (losses)
 
$
(2
)
 
$
(3
)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Three Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
56

 
$
(13
)
 
$
20

 
$
(356
)
 
$
980


$
1,730

 
$
(15
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
21

 

Net derivative gains (losses)
 
9

 
6

 
(2
)
 
(45
)
 
255

 

 

Policyholder benefits and claims
 

 

 

 
2

 
8

 

 

OCI
 
11

 
1

 

 

 
(18
)
 

 

Purchases (3)
 

 

 

 
4

 

 
131

 

Sales (3)
 

 

 

 

 

 
(104
)
 

Issuances (3)
 

 

 
(1
)
 

 

 
58

 

Settlements (3)
 
(40
)
 
3

 

 

 
(205
)
 
(27
)
 

Transfers into Level 3 (4)
 

 

 

 

 

 
4

 

Transfers out of Level 3 (4)
 

 

 

 

 

 
(122
)
 

Balance, end of period
 
$
36

 
$
(3
)
 
$
17

 
$
(395
)
 
$
1,020

 
$
1,691

 
$
(15
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$
(1
)
 
$
4

 
$
(1
)
 
$
(46
)
 
$
262

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
2

 
$
8

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Three Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
6,426

 
$
5,825

 
$
2,203

 
$
115

 
$
2,426

 
$
1,084

 
$
3,766

 
$
53

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
4

 
4

 
2

 

 
2

 

 
5

 

Net investment gains (losses)
 
(29
)
 
(3
)
 

 

 
4

 
(2
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
(169
)
 
(168
)
 
(48
)
 
(2
)
 
14

 
(6
)
 
(37
)
 
(1
)
Purchases (3)
 
553

 
642

 
234

 

 
524

 
184

 
359

 
17

Sales (3)
 
(281
)
 
(135
)
 
(47
)
 
(42
)
 
(198
)
 
(113
)
 
(256
)
 
(5
)
Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
121

 
201

 
3

 
16

 
49

 
46

 

 

Transfers out of Level 3 (4)
 
(707
)
 
(358
)
 
(376
)
 
(5
)
 
(86
)
 
(143
)
 
(79
)
 
(23
)
Balance, end of period
 
$
5,918

 
$
6,008

 
$
1,971

 
$
82

 
$
2,735

 
$
1,050

 
$
3,758

 
$
41

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
3

 
$
4

 
$
2

 
$

 
$
9

 
$

 
$
5

 
$

Net investment gains (losses)
 
$
(28
)
 
$

 
$

 
$

 
$
(1
)
 
$
(2
)
 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans - FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Three Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
189

 
$
401

 
$
14

 
$
44

 
$
831

 
$

 
$
2,130

 
$

 
$
2

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
2

 
(17
)
 

 
2

 

 

Net investment gains (losses)
 

 
1

 

 

 

 

 
4

 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
(4
)
 
8

 

 

 

 

 
(38
)
 

 

Purchases (3)
 
8

 
20

 
1

 

 
341

 

 
247

 
150

 

Sales (3)
 
(7
)
 
(22
)
 
(4
)
 

 
(481
)
 

 
(1,783
)
 

 
(2
)
Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
1

 

 
2

 

 
36

 

 

 

 

Transfers out of Level 3 (4)
 
(4
)
 

 
(2
)
 

 
(117
)
 

 
(218
)
 

 

Balance, end of period
 
$
183

 
$
408

 
$
11

 
$
46

 
$
593

 
$

 
$
344

 
$
150

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
3

 
$
(9
)
 
$

 
$
1

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$
1

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Three Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
144

 
$
30

 
$
38

 
$
(139
)
 
$
(1,584
)
 
$
1,219

 
$
(31
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
(15
)
 

Net derivative gains (losses)
 
(26
)
 
(25
)
 
(10
)
 
(33
)
 
1,031

 

 

Policyholder benefits and claims
 

 

 

 
(3
)
 
(33
)
 

 

OCI
 
(7
)
 
2

 
(3
)
 

 
105

 

 

Purchases (3)
 

 
2

 

 
4

 

 
117

 

Sales (3)
 

 

 

 

 

 
(39
)
 

Issuances (3)
 

 
(1
)
 

 

 

 

 

Settlements (3)
 
(12
)
 
(2
)
 

 

 
(197
)
 
(19
)
 

Transfers into Level 3 (4)
 

 

 

 

 

 
5

 

Transfers out of Level 3 (4)
 
(1
)
 

 

 

 

 
(43
)
 

Balance, end of period
 
$
98

 
$
6

 
$
25

 
$
(171
)
 
$
(678
)
 
$
1,225

 
$
(31
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$
(21
)
 
$
(26
)
 
$
(10
)
 
$
(34
)
 
$
1,024

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
(3
)
 
$
(31
)
 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Six Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,148

 
$
6,704

 
$
2,235

 
$
62

 
$
2,957

 
$
972

 
$
4,210

 
$
10

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
4

 
4

 
98

 

 
35

 

 
5

 

Net investment gains (losses)
 

 
(1
)
 
(4
)
 

 
8

 

 
(38
)
 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
268

 
298

 
(77
)
 

 
68

 
(32
)
 
63

 
1

Purchases (3)
 
863

 
716

 
179

 
301

 
1,176

 
61

 
2,098

 
2

Sales (3)
 
(562
)
 
(240
)
 
(109
)
 
(1
)
 
(377
)
 
(172
)
 
(567
)
 

Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
464

 
517

 
312

 

 
146

 
11

 
548

 
32

Transfers out of Level 3 (4)
 
(816
)
 
(1,386
)
 
(962
)
 
(42
)
 
(68
)
 
(245
)
 
(2,533
)
 
(10
)
Balance, end of period
 
$
7,369

 
$
6,612

 
$
1,672

 
$
320

 
$
3,945

 
$
595

 
$
3,786

 
$
35

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
2

 
$
7

 
$
3

 
$

 
$
24

 
$

 
$

 
$

Net investment gains (losses)
 
$
(7
)
 
$
(2
)
 
$

 
$

 
$
(1
)
 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Six Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
177

 
$
395

 
$
12

 
$
29

 
$
603

 
$

 
$
254

 
$
338

 
$

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
11

 
12

 

 
1

 
11

 

Net investment gains (losses)
 
(2
)
 
(3
)
 

 

 

 

 

 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
43

 
14

 

 

 

 

 
(1
)
 

 

Purchases (3)
 
21

 

 
20

 

 
318

 

 
192

 
51

 

Sales (3)
 
(14
)
 

 
(5
)
 

 
(368
)
 
(1
)
 
(76
)
 
(8
)
 

Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 
(25
)
 

Transfers into Level 3 (4)
 
40

 

 

 
69

 
27

 
12

 

 

 

Transfers out of Level 3 (4)
 
(79
)
 
(143
)
 
(7
)
 

 
(21
)
 

 
(124
)
 

 

Balance, end of period
 
$
186

 
$
263

 
$
20

 
$
109

 
$
571

 
$
11

 
$
246

 
$
367

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
11

 
$
14

 
$

 
$
1

 
$
11

 
$

Net investment gains (losses)
 
$
(2
)
 
$
(3
)
 
$

 
$

 
$

 
$
(1
)
 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Six Months Ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
13

 
$
(11
)
 
$
29

 
$
(317
)
 
$
1,258

 
$
1,465

 
$
(28
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
65

 

Net derivative gains (losses)
 
15

 
8

 
(9
)
 
(87
)
 
160

 

 

Policyholder benefits and claims
 

 

 

 
6

 
23

 

 

OCI
 
49

 

 

 
(1
)
 
(24
)
 

 

Purchases (3)
 

 

 

 
4

 

 
348

 

Sales (3)
 

 

 

 

 

 
(192
)
 

Issuances (3)
 

 

 
(3
)
 

 

 
82

 

Settlements (3)
 
(41
)
 

 

 

 
(397
)
 
(28
)
 
13

Transfers into Level 3 (4)
 

 

 

 

 

 
2

 

Transfers out of Level 3 (4)
 

 

 

 

 

 
(51
)
 

Balance, end of period
 
$
36

 
$
(3
)
 
$
17

 
$
(395
)
 
$
1,020

 
$
1,691

 
$
(15
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$
7

 
$
(7
)
 
$
(87
)
 
$
168

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
6

 
$
24

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Six Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,433

 
$
6,208

 
$
1,814

 
$
71

 
$
2,037

 
$
1,147

 
$
3,656

 
$
54

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
8

 
6

 
8

 

 
10

 
(1
)
 
8

 

Net investment gains (losses)
 
(32
)
 
(23
)
 
5

 

 
2

 
(2
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
(9
)
 
(161
)
 
(47
)
 
(2
)
 
124

 
(49
)
 
(62
)
 
(1
)
Purchases (3)
 
684

 
794

 
352

 

 
803

 
404

 
985

 
17

Sales (3)
 
(659
)
 
(413
)
 
(74
)
 
(4
)
 
(168
)
 
(333
)
 
(420
)
 
(5
)
Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
241

 
185

 
91

 
17

 
21

 
139

 

 

Transfers out of Level 3 (4)
 
(1,748
)
 
(588
)
 
(178
)
 

 
(94
)
 
(255
)
 
(409
)
 
(24
)
Balance, end of period
 
$
5,918

 
$
6,008

 
$
1,971

 
$
82

 
$
2,735

 
$
1,050

 
$
3,758

 
$
41

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
7

 
$
5

 
$
8

 
$

 
$
17

 
$
(1
)
 
$
8

 
$

Net investment gains (losses)
 
$
(34
)
 
$
(3
)
 
$

 
$

 
$
(1
)
 
$
(2
)
 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Six Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
190

 
$
419

 
$
6

 
$
32

 
$
937

 
$

 
$
429

 
$

 
$
49

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
5

 
(24
)
 

 
2

 

 

Net investment gains (losses)
 

 
(29
)
 

 

 

 

 
(24
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
(7
)
 
65

 

 

 

 

 
11

 

 

Purchases (3)
 
12

 
23

 
3

 

 
340

 

 
332

 
150

 

Sales (3)
 
(9
)
 
(70
)
 

 
(5
)
 
(427
)
 

 
(400
)
 

 
(45
)
Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

 
(4
)
Transfers into Level 3 (4)
 
1

 

 
2

 
14

 
58

 

 

 

 

Transfers out of Level 3 (4)
 
(4
)
 

 

 

 
(291
)
 

 
(6
)
 

 

Balance, end of period
 
$
183

 
$
408

 
$
11

 
$
46

 
$
593

 
$

 
$
344

 
$
150

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
5

 
$
(12
)
 
$

 
$
1

 
$

 
$

Net investment gains (losses)
 
$

 
$
(20
)
 
$

 
$

 
$

 
$

 
$
1

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Six Months Ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
177

 
$
37

 
$
43

 
$
128

 
$
(3,162
)
 
$
1,205

 
$
(44
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 

 
(1
)
Net derivative gains (losses)
 
(22
)
 
(34
)
 
(15
)
 
(305
)
 
2,721

 

 

Policyholder benefits and claims
 

 

 

 
9

 
(80
)
 

 

OCI
 
(31
)
 
1

 
(3
)
 

 
209

 

 

Purchases (3)
 

 
2

 

 
4

 

 
175

 

Sales (3)
 

 

 

 

 

 
(78
)
 

Issuances (3)
 

 
(1
)
 

 

 

 

 

Settlements (3)
 
(25
)
 
1

 

 
(7
)
 
(366
)
 
(28
)
 
14

Transfers into Level 3 (4)
 

 

 

 

 

 
7

 

Transfers out of Level 3 (4)
 
(1
)
 

 

 

 

 
(56
)
 

Balance, end of period
 
$
98

 
$
6

 
$
25

 
$
(171
)
 
$
(678
)
 
$
1,225

 
$
(31
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$
(1
)
Net derivative gains (losses)
 
$
(17
)
 
$
(34
)
 
$
(15
)
 
$
(305
)
 
$
2,707

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
10

 
$
(77
)
 
$

 
$

__________________
(1)
Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities and mortgage loans held-for-sale are included in net investment gains (losses), while changes in estimated fair value of mortgage loans - FVO are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses).
(2)
Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
(3)
Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
(4)
Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(5)
Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods.
(6)
Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(7)
Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(8)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses).
Fair Value Option
The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.
 
 
Residential Mortgage
Loans — FVO (1)
 
Certain Assets
and Liabilities
of CSEs — FVO (2)
 
 
June 30, 2014
 
December 31, 2013
 
June 30, 2014
 
December 31, 2013
 
 
(In millions)
Assets
 
 
 
 
 
 
 
 
Unpaid principal balance
 
$
546

 
$
508

 
$
582

 
$
1,528

Difference between estimated fair value and unpaid principal balance
 
(179
)
 
(170
)
 
56

 
70

Carrying value at estimated fair value
 
$
367

 
$
338

 
$
638

 
$
1,598

Loans in non-accrual status
 
$
132

 
$

 
$

 
$

Loans more than 90 days past due
 
$
87

 
$
81

 
$

 
$

Loans in non-accrual status or more than 90 days past due, or both — difference between aggregate estimated fair value and unpaid principal balance
 
$
(103
)
 
$
(82
)
 
$

 
$

Liabilities
 
 
 
 
 
 
 
 
Contractual principal balance
 
 
 
 
 
$
512

 
$
1,445

Difference between estimated fair value and contractual principal balance
 
 
 
 
 
(7
)
 
10

Carrying value at estimated fair value
 
 
 
 
 
$
505

 
$
1,455

__________________
(1)
Interest income, changes in estimated fair value and gains or losses on sales are recognized in net investment income. Changes in estimated fair value for these loans were due to the following:
 
 
Three Months 
 Ended 
 June 30,
 
Six Months 
 Ended 
 June 30,
 
 
2014
 
2013
 
2014
 
2013
 
 
(In millions)
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality
 
$
3

 
$

 
$
5

 
$

Other changes in estimated fair value
 
3

 

 
4

 

Total gains (losses) recognized in net investment income
 
$
6

 
$

 
$
9

 
$

(2)
These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.
Nonrecurring Fair Value Measurements
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
 
At June 30,
 
Three Months 
 Ended 
 June 30,
 
Six Months 
 Ended 
 June 30,
 
2014
 
2013
 
2014
 
2013
 
2014
 
2013
 
Carrying Value After Measurement
 
Gains (Losses)
 
(In millions)
Mortgage loans, net (1)
$
146

 
$
242

 
$
(1
)
 
$
10

 
$
(2
)
 
$
17

Other limited partnership interests (2)
$
69

 
$
70

 
$
(35
)
 
$
(39
)
 
$
(37
)
 
$
(39
)
Real estate joint ventures (3)
$

 
$
3

 
$

 
$

 
$

 
$
(2
)
__________________
(1)
Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.
(2)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both June 30, 2014 and 2013 were not significant.
(3)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate and mezzanine debt. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both June 30, 2014 and 2013 were not significant.
Fair Value of Financial Instruments Carried at Other Than Fair Value
The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions, short-term debt and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “ — Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure.
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
 
June 30, 2014
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
56,218

 
$

 
$

 
$
59,194

 
$
59,194

Policy loans
$
11,785

 
$

 
$
1,689

 
$
11,769

 
$
13,458

Real estate joint ventures
$
92

 
$

 
$

 
$
171

 
$
171

Other limited partnership interests
$
847

 
$

 
$

 
$
1,085

 
$
1,085

Other invested assets
$
656

 
$
216

 
$
95

 
$
345

 
$
656

Premiums, reinsurance and other receivables
$
4,014

 
$

 
$
1,642

 
$
2,420

 
$
4,062

Other assets
$
1,057

 
$

 
$
974

 
$
76

 
$
1,050

Liabilities
 
 
 
 
 
 
 
 
 
PABs
$
138,216

 
$

 
$

 
$
144,112

 
$
144,112

Long-term debt
$
16,248

 
$

 
$
18,293

 
$

 
$
18,293

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,993

 
$
3,993

Junior subordinated debt securities
$
3,193

 
$

 
$
4,131

 
$

 
$
4,131

Other liabilities
$
5,900

 
$

 
$
4,610

 
$
1,293

 
$
5,903

Separate account liabilities
$
119,236

 
$

 
$
119,236

 
$

 
$
119,236

 
December 31, 2013
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
55,770

 
$

 
$

 
$
57,924

 
$
57,924

Policy loans
$
11,764

 
$

 
$
1,694

 
$
11,512

 
$
13,206

Real estate joint ventures
$
102

 
$

 
$

 
$
169

 
$
169

Other limited partnership interests
$
950

 
$

 
$

 
$
1,109

 
$
1,109

Other invested assets
$
844

 
$
322

 
$
163

 
$
359

 
$
844

Premiums, reinsurance and other receivables
$
3,116

 
$

 
$
728

 
$
2,382

 
$
3,110

Other assets
$
324

 
$

 
$
210

 
$
142

 
$
352

Liabilities
 
 
 
 
 
 
 
 
 
PABs
$
139,735

 
$

 
$

 
$
144,631

 
$
144,631

Long-term debt
$
17,170

 
$

 
$
18,564

 
$

 
$
18,564

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,984

 
$
3,984

Junior subordinated debt securities
$
3,193

 
$

 
$
3,789

 
$

 
$
3,789

Other liabilities
$
2,239

 
$

 
$
948

 
$
1,292

 
$
2,240

Separate account liabilities
$
117,562

 
$

 
$
117,562

 
$

 
$
117,562

The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:
Mortgage Loans
The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.
Policy Loans
Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.
Real Estate Joint Ventures and Other Limited Partnership Interests
The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.
Other Invested Assets
These other invested assets are principally comprised of various interest-bearing assets held in foreign subsidiaries and certain amounts due under contractual indemnifications. For the various interest-bearing assets held in foreign subsidiaries, the Company evaluates the specific facts and circumstances of each instrument to determine the appropriate estimated fair values. These estimated fair values were not materially different from the recognized carrying values.
Premiums, Reinsurance and Other Receivables
Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.
Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.
The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.
Other Assets
These other assets are principally comprised of a receivable for funds due but not yet settled and a receivable for cash paid to an unaffiliated financial institution under the MetLife Reinsurance Company of Charleston (“MRC”) collateral financing arrangement described in Note 13 of the Notes to the Consolidated Financial Statements included in the 2013 Annual Report. The estimated fair value of the receivable for the cash paid to the unaffiliated financial institution under the MRC collateral financing arrangement is determined by discounting the expected future cash flows using a discount rate that reflects the credit rating of the unaffiliated financial institution.
PABs
These PABs include investment contracts. Embedded derivatives on investment contracts and certain variable annuity guarantees accounted for as embedded derivatives are excluded from this caption in the preceding tables as they are separately presented in “— Recurring Fair Value Measurements.”
The investment contracts primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.
Long-term Debt, Collateral Financing Arrangements and Junior Subordinated Debt Securities
The estimated fair values of long-term debt and junior subordinated debt securities are principally determined using market standard valuation methodologies. Capital leases, which are not required to be disclosed at estimated fair value are excluded from the preceding tables.
Valuations classified as Level 2 are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues.
Valuations classified as Level 3 are based primarily on discounted cash flow methodologies that utilize unobservable discount rates that can vary significantly based upon the specific terms of each individual arrangement. The determination of estimated fair values of collateral financing arrangements incorporates valuations obtained from the counterparties to the arrangements, as part of the collateral management process.
Other Liabilities
Other liabilities consist primarily of interest and dividends payable, amounts due for securities purchased but not yet settled, funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements, and amounts payable under certain assumed reinsurance agreements, which are recorded using the deposit method of accounting. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values, with the exception of certain deposit type reinsurance payables. For such payables, the estimated fair value is determined as the present value of expected future cash flows, which are discounted using an interest rate determined to reflect the appropriate credit standing of the assuming counterparty.
Separate Account Liabilities
Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.
Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance, funding agreements related to group life contracts and certain contracts that provide for benefit funding.
Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.